Prostate cancer: open trials in Chile

• NCT06136624

  Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)

  Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC

  Bradford Hill Norte ( Site 0357), Antofagasta · IC La Serena Research ( Site 0356), La Serena · Fundación Arturo López Pérez ( Site 0353), Santiago · Pontificia Universidad Catolica de Chile-Hemato-Oncology ( Site 0354), Santiago · Bradfordhill-Clinical Area ( Site 0351), Santiago · Clinica Universidad Catolica del Maule-Oncology ( Site 0355), Talca · Clinical Research Chile SpA ( Site 0358), Valdivia

  Registry updated 2026-11-05

• NCT06629779

  A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.

  Trial Treatment · Phase 3 · Pfizer

  Ic La Serena Research, La Serena · Oncovida, Providencia · Fundación Arturo Lopéz Pérez, Providencia · FALP, Santiago · Centro de Estudios Clínicos SAGA, Santiago · Bradfordhill, Santiago · Clinica Universidad Catolica del Maule, Talca · Centro de Investigacion Clinica del Sur, Temuco · Oncocentro Apys, Viña del Mar

  Registry updated 2026-10-30

• NCT06925737

  A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)

  Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC

  Fundacion Arturo Lopez Perez ( Site 0201), Santiago · Bradfordhill ( Site 0200), Santiago

  Registry updated 2026-10-30

• NCT06136650

  A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)

  Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC

  Pontificia Universidad Catolica de Chile-Hemato-Oncology ( Site 0304), Santiago · Bradfordhill-Clinical Area ( Site 0301), Santiago · Fundación Arturo López Pérez ( Site 0303), Santiago · Clinica Universidad Catolica del Maule-Oncology ( Site 0306), Talca · CIDO SpA-Oncology ( Site 0302), Temuco · ONCOCENTRO APYS-ACEREY ( Site 0305), Viña del Mar

  Registry updated 2026-10-20

• NCT06952803

  A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation

  Trial Treatment · Phase 3 · AstraZeneca

  Concepción · La Serena · Temuco

  Registry updated 2026-10-14

• NCT06863272

  A Clinical Study of Ifinatamab Deruxtecan Based Treatment Combinations or as Monotherapy to Treat Metastatic Castrate Resistant Prostate Cancer (mCRPC) (MK-2400-01A/IDeate-Prostate02)

  Trial Treatment · Phase 1/2 · Merck Sharp & Dohme LLC

  Bradfordhill ( Site 0231), Santiago · Centro de Oncología de Precisión ( Site 0241), Santiago · Fundación Arturo López Pérez ( Site 0232), Santiago · Clinica Universidad Catolica del Maule ( Site 0236), Talca · ONCOCENTRO APYS ( Site 0234), Viña del Mar

  Registry updated 2026-10-09

• NCT03678025

  Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

  Trial Treatment · Phase 3 · SWOG Cancer Research Network

  Instituto Nacional del Cancer, Independence

  Registry updated 2026-10-08

All Prostate cancer trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error